What Does Research Say About Mebendazole for Brain Cancer (Glioblastoma)?

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Research Evidence: Mebendazole for Brain Cancer (Glioblastoma)

This page summarizes what the published scientific literature reports about Mebendazole in the context of Brain Cancer (Glioblastoma). It is intended to help patients and caregivers prepare for informed conversations with their healthcare team.

Current State of the Evidence

Preclinical studies (in vitro and animal models) have demonstrated anti-tumor activity in cell lines and animal models of this cancer type. Some compounds have progressed to early-phase clinical trials (Phase I/II), primarily focused on safety and preliminary efficacy signals. Results from observational studies and retrospective analyses provide hypothesis-generating data. Large-scale randomized controlled trials establishing clinical benefit in this indication are limited or not yet completed for most investigational compounds. Patients should discuss the current evidence landscape with their oncologist.

For Mebendazole specifically in Glioblastoma, the evidence base should be reviewed with an understanding of its current classification — primarily preclinical or early-phase clinical — and interpreted accordingly.

Clinical Trial Landscape

Clinical trials investigating Mebendazole in Glioblastoma (or related conditions) may be found on ClinicalTrials.gov by searching for the compound name and disease. Trial status changes frequently; any information on this page may not reflect the most current recruitment status.

Interpreting the Evidence

  • Preclinical data: Laboratory and animal studies — important but not sufficient to establish human benefit
  • Phase I trials: Primarily safety data in small patient populations
  • Phase II trials: Preliminary efficacy signals, still small scale
  • Phase III trials: Large-scale efficacy — the standard required for regulatory approval

Discussing This Research With Your Neuro-Oncologist

Bring specific questions about the evidence level, ongoing trials, and applicability to your case. Insight Swarm's personalized reports can help you organize and contextualize this information before your appointment.


Medical Disclaimer: This page summarizes published research and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.

Get a personalized research report for your specific situation at insightswarm.ai.

Frequently Asked Questions

What Does Research Say About Mebendazole for Brain Cancer (Glioblastoma)?

Based on published research, Mebendazole has been investigated in the context of Brain Cancer (Glioblastoma). The current evidence is primarily preclinical, with limited clinical trial data. Discuss with your neuro-oncologist to evaluate relevance to your specific situation.

Where can I find clinical trials for Mebendazole in Brain Cancer (Glioblastoma)?

Search ClinicalTrials.gov for 'mebendazole' and 'Glioblastoma' to find currently registered and recruiting trials. Your neuro-oncologist can also help identify relevant trials.